Form CORRESP - Correspondence:
SEC Accession No. 0001144204-15-052353
Filing Date
2015-08-27
Accepted
2015-08-27 16:30:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8066
  Complete submission text file 0001144204-15-052353.txt   9281
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 8090 Services-Misc Health & Allied Services, NEC